Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urethral Neoplasms × relatlimab × Clear all

Sponsor

Conditions

Melanoma 4 Advanced Cancer 3 Uveal Melanoma 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Various Advanced Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Gemcitabine 7 Cisplatin 5 Ramucirumab 3 Platinum 3 Paclitaxel 3 Docetaxel 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 Carboplatin 2 rucaparib 1 pegfilgrastim 1 pazopanib 1 eribulin 1 enzalutamide 1 enfortumab vedotin 1 dehydroftorafur 1 cabozantinib 1 avelumab 1 atezolizumab 1 aflibercept 1 Taxes 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Specimen Handling 1 Sorafenib 1 Radiotherapy 1 Radiation 1 N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide 1 Mitozytrex 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡